
STAT+: FDA oncology head wants advisory panels to keep voting on new drugs
CHICAGO — As commissioner of the Food and Drug Administration, Robert Califf has made clear…
CHICAGO — As commissioner of the Food and Drug Administration, Robert Califf has made clear…
There’s now a two-party showdown for one of the largest home health companies in the…
WASHINGTON — Ted Love has pretty much done everything there is to do in biotech. He’s…
CHICAGO — Yescarta, the CAR-T therapy made by the Kite unit of Gilead Sciences, prolonged…
In an important reminder that plugging digital tools into a clinical trial will not magically…
Ten years ago, clinicians in a handful of hospitals around the United States began sequencing…
SAN FRANCISCO — Primary care tech startup Carbon Health is using artificial intelligence to listen…
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
In response to concerns about pollution caused by antibiotic production, an industry group is launching…
GLP-1s, a class of drugs including Ozempic and Wegovy that have become widely popular for…
This article is adapted from STAT’s latest report, Decoding Medicare: 10 key coverage decisions and…
Since a Texas judge’s decision dropped earlier this spring, Braidwood v. Becerra has sent shudders…
A $203 million tax refund for Blue Cross Blue Shield of North Carolina. Nearly $1.5…
CHICAGO — The annual meeting of the American Society of Clinical Oncology is back in…
In the third episode of “Color Code,” we take a look at efforts on Long…
The world has changed since 2018 when the Biotechnology Innovation Organization last brought its annual…
CHICAGO – Giving the AstraZeneca drug Tagrisso to patients with non-small cell lung cancer who…
CHICAGO – An experimental drug dramatically slowed the growth of glioma, a type of brain…
CHICAGO — An antibody that delivers chemotherapy directly to tumor cells extended the lives of…
A few miles can mean a life or death difference to children with cancer, if…
WASHINGTON — President Biden plans to tap longtime federal and state health official Mandy Cohen…
And so, another working week will soon draw to a close. Not a moment too…
Kisqali, a breast cancer pill made by Novartis, reduced the risk of recurrence of the…
Vince Wescott was ready for top surgery. He had the cash saved up, he’d gotten…
I’m standing over an operating table, excising a skin cancer from the forehead of an…
Several years ago, a local artist asked if she could paint my younger daughter, then…
After weeks of protest from physician organizations and patients, UnitedHealthcare has put a controversial new…
NEW YORK (AP) — Racial bias built into a common medical test for lung function…
Why are fake medical devices more lucrative than real ones? Is Ozempic a neurological treatment?…
Having insurance coverage alone doesn’t guarantee that people can afford or would be willing to…
U.S. births were flat last year, as the nation saw fewer babies born than it…
WASHINGTON — Despite pressure from Congress and advocates, Medicare isn’t changing its coverage plan for…
Good morning, everyone. Damian Garde here, filling in for Ed Silverman on the back half…
Tempus, a company that combines DNA sequencing for cancer with artificial intelligence, said Thursday that…
In a bold move, Coherus BioSciences plans to sell a biosimilar version of Humira —…
WASHINGTON — Researchers and health care advocates are warning that the debt ceiling deal would…
WASHINGTON — At first glance, the debt ceiling deal that Republicans struck with the White…
The statistics are dismal, though they bear repeating: 81% of overdose deaths in the U.S….
Last Thursday, after 15 hours of deliberation, the Indiana State Licensing board ruled that our…
Microsoft-owned Nuance Communications sells its AI medical scribe platform to health care providers on a…
The Food and Drug Administration approved a second vaccine to protect older adults against RSV…
As Congress considers wide-ranging reforms to pharmacy benefit managers, a top executive at CVS Health,…
WASHINGTON — House Republicans are ratcheting up pressure on federal agencies’ pandemic response with an…
Hey there. STAT reporter Andrew Joseph here welcoming you to Wednesday’s edition of Pharmalittle, with…
“Hey, I’m sorry to bother you, but I could really use your advice on something.”…
The high cost of cancer treatment in the U.S. is literally killing people. “Over a…
A family nurse practitioner in New York City, Jose M. Maria has come to expect…
A federal appeals court ruled Tuesday Purdue Pharma can shield its owners — members of…
WASHINGTON – Sen. Elizabeth Warren (D-Mass.) is launching a fresh round of questioning on states’…